SIMILAR PATTERNS OF AMINO ACIDS FOR 2X0Y_B_X0TB1625

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2im9 HYPOTHETICAL PROTEIN

(Legionella
pneumophila) 		PF07313
(DUF1460) 		5 ASP A 119
VAL A 122
ASN A 165
VAL A 242
ASP A 288
 None
 0.99A 2x0yB-2im9A:
undetectable		 2x0yB-2im9A:
18.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2j4g HYALURONOGLUCOSAMINI
DASE

(Bacteroides
thetaiotaomicron) 		PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase) 		9 ASP A 242
TYR A 282
THR A 310
TRP A 337
ASN A 339
VAL A 342
ASP A 344
TYR A 345
ASN A 372
 NB1  A1590 (-3.7A)
NB1  A1590 (-3.8A)
NB1  A1590 (-3.9A)
NB1  A1590 (-3.7A)
NB1  A1590 (-3.6A)
NB1  A1590 ( 4.9A)
NB1  A1590 ( 3.0A)
NB1  A1590 ( 4.8A)
NB1  A1590 (-3.4A)
 0.67A 2x0yB-2j4gA:
41.9		 2x0yB-2j4gA:
32.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2j4g HYALURONOGLUCOSAMINI
DASE

(Bacteroides
thetaiotaomicron) 		PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase) 		7 LYS A 166
THR A 310
TRP A 337
ASN A 339
VAL A 342
ASP A 344
ASN A 372
 NB1  A1590 (-3.0A)
NB1  A1590 (-3.9A)
NB1  A1590 (-3.7A)
NB1  A1590 (-3.6A)
NB1  A1590 ( 4.9A)
NB1  A1590 ( 3.0A)
NB1  A1590 (-3.4A)
 0.72A 2x0yB-2j4gA:
41.9		 2x0yB-2j4gA:
32.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2v5d O-GLCNACASE NAGJ

(Clostridium
perfringens) 		PF00754
(F5_F8_type_C)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase) 		5 LYS A 218
ASP A 297
VAL A 331
TYR A 335
TRP A 490
 None
 1.14A 2x0yB-2v5dA:
52.0		 2x0yB-2v5dA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2v5d O-GLCNACASE NAGJ

(Clostridium
perfringens) 		PF00754
(F5_F8_type_C)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase) 		6 LYS A 218
ASP A 298
VAL A 399
ASP A 401
TYR A 402
TRP A 490
 None
 1.17A 2x0yB-2v5dA:
52.0		 2x0yB-2v5dA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2v5d O-GLCNACASE NAGJ

(Clostridium
perfringens) 		PF00754
(F5_F8_type_C)
PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase) 		11 LYS A 218
VAL A 331
TYR A 335
THR A 366
TRP A 394
ASN A 396
VAL A 399
ASP A 401
TYR A 402
ASN A 429
TRP A 490
 None
 0.56A 2x0yB-2v5dA:
52.0		 2x0yB-2v5dA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xsb HYALURONOGLUCOSAMINI
DASE

(Oceanicola
granulosus) 		PF07555
(NAGidase) 		9 LYS A  39
ASP A 115
TYR A 160
THR A 191
TRP A 219
ASN A 221
ASP A 226
TYR A 227
ASN A 254
 GDL  A1436 ( 3.8A)
None
GDL  A1436 (-3.6A)
GDL  A1436 ( 4.5A)
GDL  A1436 (-3.6A)
GDL  A1436 (-3.0A)
GDL  A1436 (-3.0A)
GDL  A1436 (-4.8A)
GDL  A1436 (-3.4A)
 0.52A 2x0yB-2xsbA:
39.7		 2x0yB-2xsbA:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fid PUTATIVE OUTER
MEMBRANE PROTEIN
(LPXR)

(Salmonella
enterica) 		PF09982
(DUF2219) 		5 ASP A  32
THR A 233
ASN A 231
VAL A 228
TYR A 178
 None
GOL  A 302 (-3.8A)
GOL  A 302 (-3.3A)
None
None
 1.38A 2x0yB-3fidA:
undetectable		 2x0yB-3fidA:
20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xb6 ALPHA-D-RIBOSE
1-METHYLPHOSPHONATE
5-PHOSPHATE C-P
LYASE
ALPHA-D-RIBOSE
1-METHYLPHOSPHONATE
5-TRIPHOSPHATE
SYNTHASE SUBUNIT
PHNI

(Escherichia
coli) 		PF05861
(PhnI)
PF06007
(PhnJ) 		5 ASP D  74
THR D 106
VAL C 335
ASP D 252
TYR D 250
 None
 1.47A 2x0yB-4xb6D:
undetectable		 2x0yB-4xb6D:
17.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zxl O-GLCNACASE NAGJ

(Clostridium
perfringens) 		PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase) 		10 ASP A 297
VAL A 331
TYR A 335
THR A 366
ASN A 396
VAL A 399
ASP A 401
TYR A 402
ASN A 429
TRP A 490
 None
 0.47A 2x0yB-4zxlA:
54.3		 2x0yB-4zxlA:
99.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zxl O-GLCNACASE NAGJ

(Clostridium
perfringens) 		PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase) 		7 LYS A 218
ASN A 396
VAL A 399
ASP A 401
TYR A 402
ASN A 429
TRP A 490
 None
 0.76A 2x0yB-4zxlA:
54.3		 2x0yB-4zxlA:
99.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zxl O-GLCNACASE NAGJ

(Clostridium
perfringens) 		PF02838
(Glyco_hydro_20b)
PF07555
(NAGidase) 		10 VAL A 331
TYR A 335
THR A 366
TRP A 394
ASN A 396
VAL A 399
ASP A 401
TYR A 402
ASN A 429
TRP A 490
 None
 0.27A 2x0yB-4zxlA:
54.3		 2x0yB-4zxlA:
99.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5diy HYALURONIDASE

(Thermobaculum
terrenum) 		PF07555
(NAGidase) 		7 ASP A 119
TYR A 168
THR A 193
ASN A 223
VAL A 226
ASP A 228
ASN A 257
 None
 0.56A 2x0yB-5diyA:
42.7		 2x0yB-5diyA:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5diy HYALURONIDASE

(Thermobaculum
terrenum) 		PF07555
(NAGidase) 		6 LYS A  43
THR A 193
ASN A 223
VAL A 226
ASP A 228
ASN A 257
 None
 0.81A 2x0yB-5diyA:
42.7		 2x0yB-5diyA:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5diy HYALURONIDASE

(Thermobaculum
terrenum) 		PF07555
(NAGidase) 		7 TYR A 168
THR A 193
TRP A 221
ASN A 223
VAL A 226
ASP A 228
ASN A 257
 None
 0.43A 2x0yB-5diyA:
42.7		 2x0yB-5diyA:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m7r PROTEIN O-GLCNACASE

(Homo sapiens) 		PF07555
(NAGidase) 		6 ASP A 174
TYR A 219
THR A 250
ASN A 280
ASP A 285
TYR A 286
 None
 0.74A 2x0yB-5m7rA:
40.0		 2x0yB-5m7rA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m7r PROTEIN O-GLCNACASE

(Homo sapiens) 		PF07555
(NAGidase) 		7 TYR A 219
THR A 250
TRP A 278
ASN A 280
ASP A 285
TYR A 286
ASN A 313
 None
 0.50A 2x0yB-5m7rA:
40.0		 2x0yB-5m7rA:
22.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uhk O-GLCNACASE
TIM-BARREL DOMAIN

(Homo sapiens) 		PF07555
(NAGidase) 		9 LYS A  98
ASP A 174
TYR A 219
THR A 250
TRP A 278
ASN A 280
ASP A 285
TYR A 286
ASN A 313
 GOL  A 502 (-4.0A)
GOL  A 501 (-3.1A)
GOL  A 501 (-3.3A)
GOL  A 501 (-4.4A)
GOL  A 501 (-3.6A)
GOL  A 501 (-3.4A)
GOL  A 502 (-2.9A)
None
GOL  A 502 (-3.4A)
 0.64A 2x0yB-5uhkA:
35.6		 2x0yB-5uhkA:
24.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uhp O-GLCNACASE
TIM-BARREL DOMAIN

(Homo sapiens) 		PF07555
(NAGidase) 		8 ASP A 174
TYR A 219
THR A 250
TRP A 278
ASN A 280
ASP A 285
TYR A 286
ASN A 313
 GOL  A 501 (-2.5A)
GOL  A 501 (-3.7A)
GOL  A 501 (-4.2A)
GOL  A 501 (-3.8A)
GOL  A 501 (-3.4A)
None
None
None
 0.54A 2x0yB-5uhpA:
35.0		 2x0yB-5uhpA:
29.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vvo PROTEIN O-GLCNACASE

(Homo sapiens) 		PF07555
(NAGidase) 		8 ASP A 174
TYR A 219
THR A 250
TRP A 278
ASN A 280
ASP A 285
TYR A 286
ASN A 313
 None
 0.74A 2x0yB-5vvoA:
39.8		 2x0yB-5vvoA:
25.73